vs
Side-by-side financial comparison of Bath & Body Works, Inc. (BBWI) and WEIBO Corp (WB). Click either name above to swap in a different company.
Bath & Body Works, Inc. is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.2× WEIBO Corp). WEIBO Corp runs the higher net margin — 35.7% vs 4.8%, a 30.9% gap on every dollar of revenue. Over the past eight quarters, WEIBO Corp's revenue compounded faster (22.6% CAGR vs -26.0%).
Bath & Body Works, Inc. is an American specialty retail company based in Columbus, Ohio. It owns Bath & Body Works, posted $7.4 billion in revenue in 2023, and was listed as 481 on the 2024 Fortune 500 list of largest United States companies by revenue.
Weibo Corporation is a Chinese social network company known for the microblogging website Sina Weibo. It is based in Beijing, China.
BBWI vs WB — Head-to-Head
Income Statement — Q3 FY2026 vs Q3 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.6B | $1.3B |
| Net Profit | $77.0M | $458.3M |
| Gross Margin | 41.3% | — |
| Operating Margin | 10.1% | 29.1% |
| Net Margin | 4.8% | 35.7% |
| Revenue YoY | -1.0% | — |
| Net Profit YoY | -27.4% | — |
| EPS (diluted) | $0.37 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.6B | — | ||
| Q3 25 | $1.5B | $1.3B | ||
| Q2 25 | $1.4B | $841.7M | ||
| Q1 25 | $2.8B | $396.9M | ||
| Q4 24 | $1.6B | — | ||
| Q3 24 | $1.5B | $1.3B | ||
| Q2 24 | $1.4B | $833.4M | ||
| Q1 24 | $2.9B | $395.5M |
| Q4 25 | $77.0M | — | ||
| Q3 25 | $64.0M | $458.3M | ||
| Q2 25 | $105.0M | $234.8M | ||
| Q1 25 | $453.0M | $108.1M | ||
| Q4 24 | $106.0M | — | ||
| Q3 24 | $152.0M | $297.4M | ||
| Q2 24 | $87.0M | $164.6M | ||
| Q1 24 | $579.0M | $51.1M |
| Q4 25 | 41.3% | — | ||
| Q3 25 | 41.3% | — | ||
| Q2 25 | 45.4% | — | ||
| Q1 25 | 46.7% | — | ||
| Q4 24 | 43.5% | — | ||
| Q3 24 | 41.0% | — | ||
| Q2 24 | 43.8% | — | ||
| Q1 24 | 45.9% | — |
| Q4 25 | 10.1% | — | ||
| Q3 25 | 10.1% | 29.1% | ||
| Q2 25 | 14.7% | 30.4% | ||
| Q1 25 | 24.3% | 27.8% | ||
| Q4 24 | 13.5% | — | ||
| Q3 24 | 12.0% | 29.0% | ||
| Q2 24 | 13.5% | 28.2% | ||
| Q1 24 | 23.9% | 25.2% |
| Q4 25 | 4.8% | — | ||
| Q3 25 | 4.1% | 35.7% | ||
| Q2 25 | 7.4% | 27.9% | ||
| Q1 25 | 16.3% | 27.2% | ||
| Q4 24 | 6.6% | — | ||
| Q3 24 | 10.0% | 22.9% | ||
| Q2 24 | 6.3% | 19.8% | ||
| Q1 24 | 19.9% | 12.9% |
| Q4 25 | $0.37 | — | ||
| Q3 25 | $0.30 | — | ||
| Q2 25 | $0.49 | — | ||
| Q1 25 | $2.06 | — | ||
| Q4 24 | $0.49 | — | ||
| Q3 24 | $0.68 | — | ||
| Q2 24 | $0.38 | — | ||
| Q1 24 | $2.54 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $236.0M | $1.1B |
| Total DebtLower is stronger | $3.9B | — |
| Stockholders' EquityBook value | $-1.6B | $3.9B |
| Total Assets | $5.0B | $6.9B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $236.0M | — | ||
| Q3 25 | $364.0M | $1.1B | ||
| Q2 25 | $636.0M | $1.2B | ||
| Q1 25 | $674.0M | $1.2B | ||
| Q4 24 | $191.0M | — | ||
| Q3 24 | $514.0M | — | ||
| Q2 24 | $855.0M | $1.9B | ||
| Q1 24 | $1.1B | $2.1B |
| Q4 25 | $3.9B | — | ||
| Q3 25 | $3.9B | — | ||
| Q2 25 | $3.9B | — | ||
| Q1 25 | $3.9B | — | ||
| Q4 24 | $4.2B | — | ||
| Q3 24 | $4.2B | — | ||
| Q2 24 | $4.3B | — | ||
| Q1 24 | $4.4B | — |
| Q4 25 | $-1.6B | — | ||
| Q3 25 | $-1.5B | $3.9B | ||
| Q2 25 | $-1.5B | $3.6B | ||
| Q1 25 | $-1.4B | $3.5B | ||
| Q4 24 | $-1.7B | — | ||
| Q3 24 | $-1.7B | — | ||
| Q2 24 | $-1.7B | $3.4B | ||
| Q1 24 | $-1.6B | $3.3B |
| Q4 25 | $5.0B | — | ||
| Q3 25 | $4.8B | $6.9B | ||
| Q2 25 | $4.9B | $6.5B | ||
| Q1 25 | $4.9B | $6.7B | ||
| Q4 24 | $5.0B | — | ||
| Q3 24 | $4.9B | — | ||
| Q2 24 | $5.2B | $7.1B | ||
| Q1 24 | $5.5B | $7.3B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $80.0M | — |
| Free Cash FlowOCF − Capex | $-1.0M | — |
| FCF MarginFCF / Revenue | -0.1% | — |
| Capex IntensityCapex / Revenue | 5.1% | — |
| Cash ConversionOCF / Net Profit | 1.04× | — |
| TTM Free Cash FlowTrailing 4 quarters | $946.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $80.0M | — | ||
| Q3 25 | $-43.0M | — | ||
| Q2 25 | $188.0M | — | ||
| Q1 25 | $955.0M | — | ||
| Q4 24 | $-99.0M | — | ||
| Q3 24 | $-46.0M | — | ||
| Q2 24 | $76.0M | — | ||
| Q1 24 | $926.0M | — |
| Q4 25 | $-1.0M | — | ||
| Q3 25 | $-99.0M | — | ||
| Q2 25 | $151.0M | — | ||
| Q1 25 | $895.0M | — | ||
| Q4 24 | $-164.0M | — | ||
| Q3 24 | $-101.0M | — | ||
| Q2 24 | $30.0M | — | ||
| Q1 24 | $878.0M | — |
| Q4 25 | -0.1% | — | ||
| Q3 25 | -6.4% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 32.1% | — | ||
| Q4 24 | -10.2% | — | ||
| Q3 24 | -6.6% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 30.2% | — |
| Q4 25 | 5.1% | — | ||
| Q3 25 | 3.6% | — | ||
| Q2 25 | 2.6% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 4.0% | — | ||
| Q3 24 | 3.6% | — | ||
| Q2 24 | 3.3% | — | ||
| Q1 24 | 1.6% | — |
| Q4 25 | 1.04× | — | ||
| Q3 25 | -0.67× | — | ||
| Q2 25 | 1.79× | — | ||
| Q1 25 | 2.11× | — | ||
| Q4 24 | -0.93× | — | ||
| Q3 24 | -0.30× | — | ||
| Q2 24 | 0.87× | — | ||
| Q1 24 | 1.60× | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
BBWI
| Bath Body Works Stores | $1.2B | 77% |
| Bath Body Works Direct | $299.0M | 19% |
| Bath Body Works International | $73.0M | 5% |
WB
| Income from operations | $373.2M | 29% |
| Shares used in computing diluted net income per share attributable to Weibos shareholders | $268.1M | 21% |
| Shares used in computing basic net income per share attributable to Weibos shareholders | $238.6M | 19% |
| Value-added services | $186.1M | 14% |
| Less: Income tax expenses | $113.2M | 9% |
| Investment related income, net | $45.0M | 4% |
| Product development | $16.7M | 1% |
| General and administrative | $10.6M | 1% |
| Sales and marketing | $7.1M | 1% |
| Accretion to redeemable non-controlling interests | $3.0M | 0% |
